These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 24048686)

  • 41. Newly identified autoantibodies: relationship to idiopathic inflammatory myopathy subsets and pathogenesis.
    Gunawardena H; Betteridge ZE; McHugh NJ
    Curr Opin Rheumatol; 2008 Nov; 20(6):675-80. PubMed ID: 18946327
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cutting edge issues in polymyositis.
    Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Gorza L; Doria A
    Clin Rev Allergy Immunol; 2011 Oct; 41(2):179-89. PubMed ID: 21191666
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies.
    Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE
    Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-Jo-1 antibody in patients with polymyositis/dermatomyositis.
    Leu CC; Lan JL
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Feb; 25(1):41-7. PubMed ID: 1306148
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Absolute reduction of regulatory T cells and regulatory effect of short-term and low-dose IL-2 in polymyositis or dermatomyositis.
    Feng M; Guo H; Zhang C; Wang Y; Liang Z; Zhao X; Qin Y; Wu Y; Liu G; Gao C; Luo J
    Int Immunopharmacol; 2019 Dec; 77():105912. PubMed ID: 31669890
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients.
    Troyanov Y; Targoff IN; Tremblay JL; Goulet JR; Raymond Y; Senécal JL
    Medicine (Baltimore); 2005 Jul; 84(4):231-249. PubMed ID: 16010208
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy.
    Ichimura Y; Matsushita T; Hamaguchi Y; Kaji K; Hasegawa M; Tanino Y; Inokoshi Y; Kawai K; Kanekura T; Habuchi M; Igarashi A; Sogame R; Hashimoto T; Koga T; Nishino A; Ishiguro N; Sugimoto N; Aoki R; Ando N; Abe T; Kanda T; Kuwana M; Takehara K; Fujimoto M
    Ann Rheum Dis; 2012 May; 71(5):710-3. PubMed ID: 22258483
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis.
    Chen Z; Cao M; Plana MN; Liang J; Cai H; Kuwana M; Sun L
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1316-24. PubMed ID: 23908005
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pathogenesis of polymyositis and dermatomyositis].
    Morović-Vergles J; Mitrović J
    Reumatizam; 2012; 59(2):23-6. PubMed ID: 23745450
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dermatomyositis. Diagnosis and evaluation of dermatomyositis, polymyositis, and inclusion-body myositis.
    Krajnc I
    Adv Exp Med Biol; 1999; 455():181-6. PubMed ID: 10599341
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Recent advance in polymyositis and dermatomyositis research].
    Kohsaka H
    Nihon Rinsho; 2009 Mar; 67(3):523-8. PubMed ID: 19280927
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Recent research developments in polymyositis/dermatomyositis].
    Okiyama N; Kohsaka H
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Apr; 31(2):85-92. PubMed ID: 18446010
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical characteristics of anti-Ro52α and anti-Ro52β antibodies in dermatomyositis/polymyositis.
    Ogawa-Momohara M; Muro Y; Mitsuma T; Katayama M; Yanaba K; Nara M; Kakeda M; Akiyama M
    J Dermatol Sci; 2019 Oct; 96(1):50-52. PubMed ID: 31444014
    [No Abstract]   [Full Text] [Related]  

  • 54. The spectrum of idiopathic inflammatory myopathies in South Africa.
    Chinniah KJ; Mody GM
    Clin Rheumatol; 2021 Apr; 40(4):1437-1446. PubMed ID: 32212001
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
    Troyanov Y; Targoff IN; Payette MP; Raynauld JP; Chartier S; Goulet JR; Bourré-Tessier J; Rich E; Grodzicky T; Fritzler MJ; Joyal F; Koenig M; Senécal JL
    Medicine (Baltimore); 2014 Nov; 93(24):318-332. PubMed ID: 25500701
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Developments in the classification and treatment of the juvenile idiopathic inflammatory myopathies.
    Rider LG; Katz JD; Jones OY
    Rheum Dis Clin North Am; 2013 Nov; 39(4):877-904. PubMed ID: 24182859
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Autoantibodies to DNA mismatch repair enzymes in polymyositis/dermatomyositis and other autoimmune diseases: a possible marker of favorable prognosis.
    Muro Y; Nakashima R; Hosono Y; Sugiura K; Mimori T; Akiyama M
    Arthritis Rheumatol; 2014 Dec; 66(12):3457-62. PubMed ID: 25186186
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Polymyositis, dermatomyositis and inclusion body myositis, nosological aspects].
    Eymard B
    Presse Med; 2003 Oct; 32(35):1656-67. PubMed ID: 14631270
    [TBL] [Abstract][Full Text] [Related]  

  • 59. T-cell transcriptomics from peripheral blood highlights differences between polymyositis and dermatomyositis patients.
    Houtman M; Ekholm L; Hesselberg E; Chemin K; Malmström V; Reed AM; Lundberg IE; Padyukov L
    Arthritis Res Ther; 2018 Aug; 20(1):188. PubMed ID: 30157932
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.
    Satoh M; Tanaka S; Ceribelli A; Calise SJ; Chan EK
    Clin Rev Allergy Immunol; 2017 Feb; 52(1):1-19. PubMed ID: 26424665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.